Reproductive Medicine Associates (RMA) has been a pioneer in fertility science for decades. With an unwavering commitment to improving patient outcomes in assisted reproduction, our global network of providers and scientists consistently strive to advance the field through new research.
A relentless focus on research throughout the years has allowed the RMA network of fertility clinics, to make significant advancements in the practice of In Vitro Fertilization (IVF) that have resulted in a new standard of care for practitioners across the globe.
And while our studies vary in scope and topic, their purpose remains singular: finding ways to provide better outcomes for hopeful parents who need a little help to start their families.
Fertility Research at RMA
Since our flagship office, Reproductive Medicine Associates of New Jersey (RMANJ), was founded in 1999, our network has published hundreds of pieces of research in an effort to improve patient outcomes.
Some topics of previous research include:
- Diminished ovarian reserve
- Polycystic Ovary Syndrome (PCOS)
- Male fertility
- Oocyte vitrification (egg freezing)
- Embryo biopsy and testing
- The microbiome
- Stem cell rejuvenation
- Extended embryo culture
Over the last decade, nearly 8,000 individuals have participated in clinical trials at RMA. Now, with the opening of our new IVF laboratory in Los Angeles, patients across Southern California can enroll in current and upcoming IVF clinical trials, too.
Inclusion criteria differs for each study, and not all patients who inquire will qualify. Those who do qualify may receive a treatment benefit, including discounted or free IVF, as part of the research study.
To learn more about past trials or to inquire about participating in existing or future research, please call 424-293-8841 or click here.